首页 | 本学科首页   官方微博 | 高级检索  
检索        

晚期糖基化终产物诱导内皮细胞紧密连接改变及其机制
引用本文:李强,郭晓华,朱艳军,陈波,邓建新,黄绪亮,黄巧冰.晚期糖基化终产物诱导内皮细胞紧密连接改变及其机制[J].中国动脉硬化杂志,2006,14(6):499-502.
作者姓名:李强  郭晓华  朱艳军  陈波  邓建新  黄绪亮  黄巧冰
作者单位:南方医科大学病理生理学教研室,广东省医学休克微循环重点实验室,广东省广州市,510515
摘    要:目的探讨晚期糖基化终产物修饰蛋白对内皮细胞紧密连接带状闭合蛋白1的形态学影响,并对其机制作初步研究。方法培养人脐静脉内皮细胞,用免疫荧光染色方法显示带状闭合蛋白1在内皮细胞分布的形态和部位。观察不同浓度和不同时间晚期糖基化终产物修饰蛋白作用下内皮细胞带状闭合蛋白1的形态学变化。研究了细胞外信号调节激酶、p38丝裂原活化蛋白激酶通路抑制剂及相关特异蛋白突变体重组腺病毒转染对晚期糖基化终产物介导的内皮细胞闭合蛋白1形态学变化的影响。结果正常对照组的内皮细胞闭合蛋白1存在于细胞周边呈环状,线条清晰连续,边缘光滑流畅,晚期糖基化终产物以时间和剂量依赖的方式引起内皮细胞紧密连接带状闭合蛋白1结构形态的改变;细胞外信号调节激酶通路抑制剂或p38丝裂原活化蛋白激酶通路抑制剂均可减轻晚期糖基化终产物对闭合蛋白1的影响;转染显性失活的细胞外信号调节激酶上游激酶MEK1和p38丝裂原活化蛋白激酶上游激酶MEK6b的重组腺病毒,均可减轻晚期糖基化终产物对带状闭合蛋白1形态的影响,而转染组成性激活的MEK1和MEK6b的重组腺病毒本身即可引起内皮细胞带状闭合蛋白1形态的变化。结论晚期糖基化终产物刺激可以引起内皮细胞紧密连接蛋白带状闭合蛋白1分布和形态的变化,这一作用可能是由细胞外信号调节激酶及p38丝裂原活化蛋白激酶信号通路介导的。

关 键 词:病理学与病理生理学  晚期糖基化终产物致细胞紧密连接结构改变  免疫荧光染色  带状闭合蛋白1  血管通透性  细胞外信号调节激酶  丝裂原活化蛋白激酶
文章编号:1007-3949(2006)14-06-0499-04
收稿时间:2005-08-29
修稿时间:2006-04-04

The Mechanism of Advanced Glycation End Products-Induced Morphological Changes of Tight Junction in Endothelial Cell
LI Qiang,GUO Xiao-Hu,ZHU Yan-Jun,CHEN Bo,DENG Jian-Xin,HUANG Xu-Liang,and HUANG Qiao-Bing.The Mechanism of Advanced Glycation End Products-Induced Morphological Changes of Tight Junction in Endothelial Cell[J].Chinese Journal of Arteriosclerosis,2006,14(6):499-502.
Authors:LI Qiang  GUO Xiao-Hu  ZHU Yan-Jun  CHEN Bo  DENG Jian-Xin  HUANG Xu-Liang  and HUANG Qiao-Bing
Institution:Department of Pathophyfiolgy ,Southem Mediclal University ,the Key Laboratory of Shock and Microcirculation of Guangdong Province,Guangdong 510515,China
Abstract:Aim To investigate the effect of advanced glycation end products modified human serum albumin(AGE-HSA) on morphological changes of tight junction associated protein ZO-1 in endothelial cell and the mechanism in this pathological procedure. Methods Human umbilical vein endothelial cell(hUVEC)-derived cell line(ECV304) were incubated with AGE-HSA in different concentrations and timing. To visualize the morphological changes of tight junction protein ZO-1,the treated cell were incubated with mouse anti-ZO-1 primary antibody and then FITCanti-mouse IgG secondary antibody.The morphological changes of ZO-1 were observed with confocal microscope.The cell were pre-administrated with PD98059,a specific inhibitor of MEK1(ERK upstream kinase)or SB203580,a specific inhibitor of p38 MAP kinase,respectively,before exposed to AGE-HSA,then the cell were rinsed with DMEM for three times and exposed to AGE-HSA. The cell were transfected with dominant negative MEK1 or MEK6b(p38 upstream kinase) mutant adenoviruse,then exposed to AGE-HSA.And the cell were transfected with constitutively active MEK1 or MEK6b mutant adenoviruse. Results In normal control group,ZO-1 staining appeared as a continuous and smooth line along the regions of cell cell contact.Under the stimulation of AGE HSA,morphology of ZO-1 in endothelial cell were changed greatly in a concentration and time-dependent manner.The changes were partially blocked by PD98059 and SB203580.The transfection of dominant negative MEK1 and MEK6b mutant adenoviruse had the similar effects.The transfection of constitutively active MEK1 and MEK6b disrupted the structure of ZO-1. Conclusion AGE modified proteins can induce morphological changes of ZO-1 in endothelial cell.Activations of ERK and p38 MAP kinase pathways play an important role in this procedure.
Keywords:Advanced Glycation End Products  Tight Junction  ZO-1  Permeability  ERK  MAPK
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国动脉硬化杂志》浏览原始摘要信息
点击此处可从《中国动脉硬化杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号